Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancer News, features, and commentary about cancer-related issues Jul 19, 2024
Young Cervical Cancer, Leukemia Survivors at Greater Risk of Obstetric Complications Population-based study suggests reassurance for most, high-risk strategies for some Jun 27, 2024
'Unusual' Cancers After Pandemic; A Win in TNBC; Shortage Pauses Clinical Trial News, features, and commentary about cancer-related issues Jun 06, 2024
Fewer Suicides in Cancer Patients; Circadian Rhythm Boost; HIV Vaccine for Cancer? News, features, and commentary about cancer-related issues May 31, 2024
HPV Testing Outperforms Pap Smear for Detecting Cervical Cancer Precursor Lesions Rates of cervical intraepithelial neoplasia at 8 years similar to 3-year rates with cytology May 31, 2024
HPV Vaccination Reduces Risk of Multiple Types of Cancer in Men and Women Large cohort study provides some of the first evidence of cancer reduction after vaccination May 24, 2024
Middle School HPV Vaccination Program Boosted Uptake Offering vaccines in schools improved access in French study, but may not overcome hesitancy May 23, 2024
Cancer and Intimate-Care Products; Boost for CRC Stool Tests; Biopsy by Ultrasound? News, features, and commentary about cancer-related issues May 17, 2024
HPV Vaccination Program in England Was Effective Across Socioeconomic Groups "It is vitally important to achieve high coverage in all sectors of society," researcher says May 16, 2024
FDA Approves New Self-Collection Option for HPV Testing Provides women a way to privately collect their own samples, says maker Roche May 15, 2024
Having a PCP Important in Cervical Cancer Screening, Especially for LGB Women Lesbian, gay, and bisexual cisgender women with PCP more likely to be up-to-date with screening May 06, 2024
Major Gaps in Cancer Screening at Federally Qualified Health Centers Breast, cervical, colorectal cancer screening rates much lower than overall national rates Apr 29, 2024
Enhertu Gets Tumor-Agnostic FDA Approval for HER2-Positive Cancers About half of patients responded, duration of response as long as 19 months in three trials Apr 05, 2024
Safety of Less-Radical Surgery for Early Cervical Cancer Gathers More Evidence Growing body of data suggest it can be safe and effective in low-risk disease, says expert Mar 18, 2024
Novel Drug-Device Shows Efficacy for High-Grade Cervical Lesions Response rate doubles with the noninvasive treatment versus placebo Mar 18, 2024
Gynecologic Oncology May Face a Future of Too Few Cases, Too Many Docs Subspecialists could see only one patient a week with a new cancer diagnosis, researcher says Mar 18, 2024
Laparoscopy Quickly Abandoned in Early Cervical Cancer After LACC Results MIS roughly halved in the 2 years following the study results, national dataset shows Mar 18, 2024
Getting Prostate Cancer Drugs Sooner; Limiting Toxic Emissions; FTC Sues 'Charity' News, features, and commentary about cancer-related issues Mar 14, 2024
Knowing When to Start, Knowing When to Stop Discussions about screening recommendations can be difficult, but they're worth having Mar 11, 2024
Another COVID Toll: Over 134,000 Undiagnosed Cancers During Height of Pandemic Diagnosis rates remained low throughout 2020, with mortality increase projected Feb 22, 2024
Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer News, features, and commentary about cancer-related issues Feb 02, 2024
No Cervical Cancer After HPV Vax; Brain Tumor Blood Test; Weight Loss and Cancer News, features, and commentary about cancer-related issues Jan 26, 2024
Two Million Cancers; Casgevy OK'd for Thalassemia; Rectal Exams and Prostate Cancer News, features, and commentary about cancer-related issues Jan 19, 2024
Certain Cancer Survivors More Likely to Have Substance Use Disorder Prevalence particularly high in those recently diagnosed with head and neck and cervical cancers Jan 17, 2024
FDA Expands Pembrolizumab Approval in Cervical Cancer PD-1 inhibitor approved in combination with CRT for locally advanced disease Jan 16, 2024
KEYNOTE-A18 Data Are 'Practice-Changing' for Cervical Cancer Domenica Lorusso details the importance of modern radiotherapy in this regimen Dec 12, 2023
AI and Breast Cancer Screening; Cancer After Treatment for Sickle Cell Also in TTHealthWatch: mail-in cervical cancer screening kits Dec 09, 2023 podcast
The Treatment Landscape for Cervical Cancer Has Changed Our experts discuss the impact of new options and approaches available in the field Dec 07, 2023 video
Let's Talk Drug Prices; Restoring the Sense of Touch; Learning From Tumors in a Dish News, features, and commentary about cancer-related issues Dec 01, 2023
Mailing HPV Self-Sampling Kits to Patients Boosted Cervical Cancer Screening The strategy was effective for patients who were due or overdue for screening Nov 28, 2023
HPV Tumor DNA May Offer Early Warning of Cervical Cancer at High Risk of Relapse Worse PFS associated with circulating tumor DNA detected as early as end of treatment Nov 21, 2023
Nudging Parents Plus Auditing Providers Increased HPV Vaccine Uptake in Tweens Interventions worked best in combination, according to cluster randomized trial Nov 20, 2023
Reprogramming Tumors; Bad Stool Samples; Human Experiences in Cancer Care News, features, and commentary about cancer-related issues Nov 17, 2023
T-DXd Tied to Encouraging Survival in HER2-Expressing Gyn Cancers More responses, longer OS in subset with the highest levels of HER2 expression Nov 07, 2023
Sexual Health Suffered After Radical Hysterectomy for Early Cervical Cancer Compared with simple hysterectomy, analysis shows more sexual toxicities, worse quality of life Nov 07, 2023
Mixed Results for Tiragolumab/Atezolizumab Combo in PD-L1+ Recurrent Cervical Cancer Overall response beats historical benchmark, but misses significance target Nov 06, 2023
Adding Atezolizumab Improves Survival in Advanced Cervical Cancer Trial confirms the role of first-line checkpoint inhibition in metastatic or recurrent disease Nov 03, 2023
Antibody-Drug Conjugate Boosts Survival in Recurrent/Metastatic Cervical Cancer Tisotumab vedotin reduced risk of death by 30% compared with chemotherapy Oct 23, 2023
'Practice-Changing' Data in Locally Advanced Cervical Cancer Strategies involving immunotherapy, induction chemo move the needle for first time in decades Oct 23, 2023
Primary Care Intervention Improved Follow-Up of Abnormal Cancer Screening Results Follow-up testing within 120 days was improved with EHR reminders, patient outreach, navigation Oct 10, 2023
